EyeTechCare Announces Preliminary Results for EyeMUST, a Multicenter Clinical Trial of its EyeOP1(R) Device for Treatment of Glaucoma
6/29/2012 10:43:10 AM
More...
|
Valensa International, LLC Snaps Up Eyetech Inc. in Buying Spree
2/13/2012 8:19:03 AM
More...
|
Eyetech Inc. Release: Post-Hoc Analysis of V.I.S.I.O.N. Trial Data Showed No Association Between Macugen(R) (Pegaptanib Sodium) and Sustained Elevated Intraocular Pressure
11/7/2011 9:51:43 AM
More...
|
Eyetech Inc. Awarded QTDP Grant to Support Development of Extended-Release Formulation of Macugen(R)
11/12/2010 11:18:45 AM
More...
|
Eyetech Inc. Announces Program to Develop Extended-Release Formulation of Macugen(R)
10/14/2010 11:14:06 AM
More...
|
Eyetech Inc. Release: Phase 3 Study Presented at World Ophthalmology Congress Evaluates Investigational Use of Macugen in Patients With Diabetic Macular Edema
6/7/2010 10:24:35 AM
More...
|
Eyetech Inc. Release: Study Published in the American Journal of Ophthalmology Examines Investigational Use of Macugen in Patients With Branch Retinal Vein Occlusion (BRVO)
1/29/2010 9:23:01 AM
More...
|
Eyetech Inc.: Study on the Investigational Use of Macugen in Patients With Diabetic Retinopathy Published in the British Journal of Ophthalmology
10/21/2009 10:59:22 AM
More...
|